The industry must adopt a science-driven, data-informed development strategy. A foundational understanding of the active pharmaceutical ingredient’s (API) physicochemical properties, the matrix characteristics, and the drug’s pharmacokinetic (PK) and pharmacodynamic (PD) profiles is essential. Leveraging these insights early in development ...
read more